FocalTherics (FOCL) Financials

$3.17 -0.07 (-2.16%)
As of 04:00 PM Eastern
Annual Income Statements for FocalTherics

Annual Income Statements for FocalTherics

This table shows FocalTherics' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-1.81 4.04 -0.82 -0.39 1.70 -2.08 0.79 -3.14 -23 -21 -29
Consolidated Net Income / (Loss)
-1.81 4.04 -0.82 -0.39 1.70 -2.08 0.79 -3.14 -23 -21 -29
Net Income / (Loss) Continuing Operations
-1.81 4.04 -0.82 -0.39 1.70 -2.08 0.79 -3.14 -23 -21 -29
Total Pre-Tax Income
-0.99 4.68 -0.35 0.02 2.46 -1.45 1.01 -2.24 -23 -20 -29
Total Operating Income
0.53 0.41 -2.43 -1.51 2.47 0.33 -1.82 -4.55 -22 -22 -25
Total Gross Profit
15 17 18 19 24 22 21 26 27 29 30
Total Revenue
35 37 43 45 50 51 50 59 67 69 71
Operating Revenue
35 37 43 45 50 51 50 59 67 69 71
Total Cost of Revenue
20 20 25 25 27 28 29 33 40 41 41
Operating Cost of Revenue
20 20 25 25 27 28 29 33 40 41 41
Total Operating Expenses
14 17 20 21 21 22 23 30 49 51 55
Selling, General & Admin Expense
3.48 3.47 4.12 4.11 4.74 5.30 6.68 7.65 16 15 18
Marketing Expense
8.05 9.32 11 12 12 11 12 18 25 27 27
Research & Development Expense
2.92 4.07 4.66 4.68 4.18 5.49 3.85 5.26 7.70 8.36 9.66
Total Other Income / (Expense), net
-1.52 4.26 2.08 1.53 -0.01 -1.78 2.84 2.31 -0.80 1.95 -4.11
Interest & Investment Income
- - - - - - - 0.25 1.19 0.61 -3.11
Other Income / (Expense), net
0.76 0.11 -1.09 0.62 0.15 -1.66 2.67 2.06 -1.99 1.35 -1.00
Income Tax Expense
0.82 0.63 0.47 0.41 0.76 0.63 0.22 0.90 0.71 0.31 0.44
Basic Earnings per Share
($0.07) $0.14 ($0.02) ($0.01) $0.05 ($0.06) $0.02 ($0.10) ($0.63) ($0.55) ($0.78)
Weighted Average Basic Shares Outstanding
25.02M 27.82M 28.96M 29.00M 29.02M 29.15M 32.13M 34.39M 37.00M 37.29M 37.44M
Diluted Earnings per Share
($0.07) $0.13 ($0.02) ($0.01) $0.05 ($0.06) $0.02 ($0.10) ($0.63) ($0.55) ($0.78)
Weighted Average Diluted Shares Outstanding
25.02M 29.37M 28.96M 29.00M 29.62M 29.15M 32.42M 34.39M 37.00M 37.29M 37.44M
Weighted Average Basic & Diluted Shares Outstanding
25.38M 28.73M 29.00M 29.00M 29.14M 29.17M 33.47M 36.91M 37.10M 37.39M 37.48M

Quarterly Income Statements for FocalTherics

This table shows FocalTherics' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-7.44 -6.41 -5.94 -9.08 -14 -4.46
Consolidated Net Income / (Loss)
-7.44 -6.41 -5.94 -9.08 -14 -4.46
Net Income / (Loss) Continuing Operations
-7.44 -6.35 -6.66 -9.08 -14 -5.29
Total Pre-Tax Income
-7.30 -6.34 -6.65 -8.94 -14 -5.27
Total Operating Income
-6.31 -6.62 -6.67 -7.37 -8.03 -7.78
Total Gross Profit
5.99 4.86 3.65 8.15 7.34 5.05
Total Revenue
14 9.51 7.83 18 13 9.83
Operating Revenue
14 9.51 7.83 18 13 9.83
Total Cost of Revenue
8.27 4.65 4.18 9.67 5.87 4.78
Operating Cost of Revenue
8.27 4.65 4.18 9.67 5.87 4.78
Total Operating Expenses
12 11 10 16 15 13
Selling, General & Admin Expense
3.65 3.90 3.83 5.79 5.52 4.46
Marketing Expense
6.07 5.30 4.18 7.12 7.54 5.91
Research & Development Expense
2.58 2.29 2.30 2.60 2.32 2.46
Total Other Income / (Expense), net
-0.99 0.28 0.03 -1.57 -6.37 2.51
Interest & Investment Income
0.02 -0.08 -0.06 -1.71 -6.30 2.04
Other Income / (Expense), net
-1.01 0.36 0.09 0.14 -0.08 0.47
Income Tax Expense
0.14 0.01 0.02 0.15 0.01 0.02
Net Income / (Loss) Discontinued Operations
- -0.05 0.72 - -0.08 0.83
Basic Earnings per Share
($0.20) ($0.17) ($0.16) ($0.24) ($0.39) ($0.10)
Weighted Average Basic Shares Outstanding
37.39M 37.42M 37.44M 37.48M 37.53M 42.63M
Diluted Earnings per Share
($0.20) ($0.17) ($0.16) ($0.24) ($0.39) ($0.10)
Weighted Average Diluted Shares Outstanding
37.39M 37.42M 37.44M 37.48M 37.53M 42.63M
Weighted Average Basic & Diluted Shares Outstanding
- - - 37.48M 37.53M 47.22M

Annual Cash Flow Statements for FocalTherics

This table details how cash moves in and out of FocalTherics' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
2.65 8.85 -2.38 -0.62 1.60 4.65 25 17 -22 -17 -11
Net Cash From Operating Activities
1.32 1.27 -3.67 0.20 4.26 2.42 5.03 -3.24 -16 -15 -16
Net Cash From Continuing Operating Activities
1.32 1.27 -3.68 0.20 4.27 2.42 5.03 -3.24 -16 -15 -16
Net Income / (Loss) Continuing Operations
-1.81 4.04 -0.82 -0.39 1.70 -2.08 0.79 -3.14 -23 -21 -29
Consolidated Net Income / (Loss)
-1.81 4.04 -0.82 -0.39 1.70 -2.08 0.79 -3.14 -23 -21 -29
Depreciation Expense
1.09 1.08 1.89 1.84 2.11 2.57 2.17 1.72 2.12 2.78 3.41
Amortization Expense
- - - - - - - - - 0.00 2.87
Non-Cash Adjustments To Reconcile Net Income
2.13 -3.83 -2.66 0.03 0.58 1.45 2.51 2.67 8.06 5.15 4.01
Changes in Operating Assets and Liabilities, net
-0.09 -0.02 -2.09 -1.29 -0.12 0.48 -0.44 -4.48 -2.99 -2.04 2.56
Net Cash From Investing Activities
-0.59 -0.40 -2.44 -1.80 -1.72 -2.46 -1.85 -2.54 -4.81 -4.46 -5.72
Net Cash From Continuing Investing Activities
-0.59 -0.40 -2.44 -1.80 -1.72 -2.46 -1.86 -2.54 -4.81 -4.46 -5.72
Purchase of Property, Plant & Equipment
-0.68 -1.24 -0.76 -0.69 -0.44 -0.65 -0.44 -0.66 -1.30 -1.42 -1.21
Acquisitions
-0.02 -0.16 -0.54 -0.50 -0.04 -0.13 -0.10 -0.15 -0.59 -0.25 -0.83
Other Investing Activities, net
-0.01 -0.06 -1.24 -1.01 -1.24 -1.68 -1.31 -1.74 -2.91 -2.79 -3.67
Net Cash From Financing Activities
2.29 8.00 3.45 1.35 -0.75 3.91 23 23 -1.01 5.02 8.61
Net Cash From Continuing Financing Activities
2.29 8.00 3.45 1.35 -0.75 3.91 23 23 -1.01 5.02 8.61
Repayment of Debt
0.22 -0.61 -0.65 -0.92 -1.42 -1.03 -2.05 -1.23 -2.02 -1.93 -2.92
Issuance of Debt
0.75 2.09 3.30 2.26 0.77 4.86 0.39 0.27 0.73 6.82 12
Other Financing Activities, net
0.14 0.00 0.14 0.00 -0.10 0.07 0.50 0.74 0.29 0.13 0.00
Effect of Exchange Rate Changes
-0.38 -0.02 0.28 -0.37 -0.20 0.78 -0.66 -0.42 0.30 -2.89 2.97

Quarterly Cash Flow Statements for FocalTherics

This table details how cash moves in and out of FocalTherics' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-6.31 -5.62 -6.66 -5.44 6.53 35
Net Cash From Operating Activities
-5.34 -4.71 -3.91 -2.97 -3.69 -4.02
Net Cash From Continuing Operating Activities
-5.34 -4.71 -3.91 -2.97 -3.69 -4.02
Net Income / (Loss) Continuing Operations
-7.44 -6.41 -5.94 -9.08 -14 -4.46
Consolidated Net Income / (Loss)
-7.44 -6.41 -5.94 -9.08 -14 -4.46
Depreciation Expense
0.75 0.85 0.90 0.90 1.01 1.00
Amortization Expense
0.00 - - 1.68 6.26 -1.91
Non-Cash Adjustments To Reconcile Net Income
0.44 0.82 1.28 0.67 0.98 1.57
Changes in Operating Assets and Liabilities, net
0.91 0.04 -0.14 2.87 2.55 -0.23
Net Cash From Investing Activities
-1.30 -1.61 -1.09 -0.75 -1.26 -1.35
Net Cash From Continuing Investing Activities
-1.30 -1.61 -1.09 -0.75 -1.26 -1.35
Purchase of Property, Plant & Equipment
-0.05 -0.02 -0.36 -0.41 -0.19 -0.17
Acquisitions
-0.58 -0.19 -0.02 -0.03 -0.16 -0.16
Other Investing Activities, net
-0.68 -1.40 -0.71 -0.32 -0.91 -1.02
Net Cash From Financing Activities
-1.25 0.06 -1.65 -1.37 12 40
Net Cash From Continuing Financing Activities
-1.25 0.06 -1.65 -1.37 12 40
Repayment of Debt
-0.72 -0.78 -0.73 -0.70 -0.64 -0.62
Issuance of Debt
-0.53 0.83 -0.92 -0.67 12 -2.19
Issuance of Common Equity
- - - - - 43
Effect of Exchange Rate Changes
1.59 0.64 -0.01 -0.34 -0.29 -0.21

Annual Balance Sheets for FocalTherics

This table presents FocalTherics' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
42 49 56 56 60 67 87 108 101 89 79
Total Current Assets
36 43 48 46 47 55 76 97 87 73 57
Cash & Equivalents
15 23 24 22 23 30 53 68 48 31 20
Note & Lease Receivable
1.11 0.93 1.28 1.64 1.41 1.26 1.42 1.63 1.53 1.75 1.29
Accounts Receivable
12 9.62 14 14 13 14 12 14 20 19 15
Inventories, net
6.68 8.45 8.10 8.25 9.18 9.76 8.49 13 17 19 7.77
Other Current Assets
0.54 0.48 0.59 0.44 0.50 0.45 0.66 0.71 0.73 1.31 1.15
Other Current Nonoperating Assets
- - - - - - - - - - 12
Plant, Property, & Equipment, net
2.31 2.91 4.42 0.00 4.57 4.52 4.09 4.49 7.16 8.09 8.79
Total Noncurrent Assets
3.72 3.49 4.38 4.76 7.75 7.45 7.05 6.85 6.58 8.73 13
Noncurrent Note & Lease Receivables
0.64 0.31 0.09 0.03 0.00 - - - - 0.00 0.53
Goodwill
2.62 2.54 2.90 2.76 2.71 2.95 2.73 2.58 2.67 2.51 0.76
Intangible Assets
0.04 0.16 0.63 0.97 0.86 0.93 0.82 0.78 1.20 1.13 1.79
Noncurrent Deferred & Refundable Income Taxes
- 0.01 0.20 0.37 0.48 0.46 1.02 0.89 0.81 0.87 0.27
Other Noncurrent Operating Assets
0.41 0.47 0.55 0.62 3.69 3.12 2.48 2.61 1.90 4.23 3.58
Other Noncurrent Nonoperating Assets
- - - - - - - - - - 6.11
Total Liabilities & Shareholders' Equity
42 49 56 56 60 67 87 108 101 89 79
Total Liabilities
26 23 26 27 29 35 31 32 38 47 60
Total Current Liabilities
18 16 19 19 20 26 20 23 31 39 37
Short-Term Debt
3.54 2.17 4.03 4.78 4.46 8.76 3.11 3.69 4.45 8.99 6.46
Accounts Payable
6.63 6.27 7.58 7.21 6.79 6.97 6.24 7.11 12 13 9.76
Current Deferred Revenue
1.74 1.98 2.76 2.21 2.12 3.30 3.86 4.33 4.48 6.90 6.45
Current Employee Benefit Liabilities
0.59 0.60 0.69 0.70 0.71 0.85 0.80 0.85 0.95 1.02 0.98
Other Taxes Payable
1.32 1.28 1.29 1.35 1.35 1.44 1.49 1.66 1.88 2.33 1.86
Other Current Liabilities
3.19 3.11 2.85 2.87 3.88 4.79 4.26 5.35 6.19 6.95 5.76
Other Current Nonoperating Liabilities
- - - - - - - - - - 5.86
Total Noncurrent Liabilities
8.56 7.50 6.73 7.97 9.22 9.09 10 8.33 7.78 7.64 22
Long-Term Debt
0.64 0.40 1.00 1.53 1.07 1.40 5.58 3.84 2.21 2.25 16
Capital Lease Obligations
0.32 0.33 0.63 0.98 0.73 0.68 0.49 0.35 0.48 0.36 0.11
Noncurrent Deferred Revenue
0.55 0.35 0.68 1.11 1.47 1.13 0.50 0.28 0.71 0.37 0.77
Other Noncurrent Operating Liabilities
7.05 6.42 4.42 4.35 5.94 5.89 3.87 3.86 4.38 4.66 2.70
Other Noncurrent Nonoperating Liabilities
- - - - - - - - - - 2.96
Total Equity & Noncontrolling Interests
16 26 30 29 31 32 57 77 63 42 19
Total Preferred & Common Equity
16 26 30 29 31 32 57 77 63 42 19
Total Common Equity
16 26 30 29 31 32 57 77 63 42 19
Common Stock
67 72 84 80 79 86 106 127 139 155 157
Retained Earnings
-46 -41 -48 -46 -43 -49 -45 -45 -70 -99 -129
Treasury Stock
-1.24 -1.20 -1.37 -1.31 -1.04 -1.13 -1.05 -0.96 -0.88 -1.02 -1.02
Accumulated Other Comprehensive Income / (Loss)
-3.88 -4.15 -4.33 -4.29 -3.86 -3.74 -4.06 -4.10 -4.96 -12 -8.34

Quarterly Balance Sheets for FocalTherics

This table presents FocalTherics' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2026 6/30/2026 9/30/2026
Total Assets
72 75 111
Total Current Assets
50 59 95
Cash & Equivalents
15 22 56
Note & Lease Receivable
0.68 0.65 0.62
Accounts Receivable
20 10 10
Inventories, net
13 8.25 8.33
Other Current Assets
1.69 1.70 2.06
Other Current Nonoperating Assets
- 17 17
Plant, Property, & Equipment, net
10 8.64 9.05
Total Noncurrent Assets
11 6.90 6.88
Noncurrent Note & Lease Receivables
1.03 1.00 0.98
Goodwill
2.77 0.74 0.73
Intangible Assets
1.72 1.77 1.83
Noncurrent Deferred & Refundable Income Taxes
1.09 0.27 0.26
Other Noncurrent Operating Assets
4.89 3.12 3.08
Other Noncurrent Nonoperating Assets
- 0.00 0.00
Total Liabilities & Shareholders' Equity
72 75 111
Total Liabilities
62 78 75
Total Current Liabilities
38 37 36
Short-Term Debt
6.70 2.71 0.76
Accounts Payable
13 10 11
Current Deferred Revenue
7.82 6.40 7.33
Current Employee Benefit Liabilities
1.23 1.03 0.85
Other Taxes Payable
2.17 2.05 1.74
Other Current Liabilities
6.87 5.35 5.31
Other Current Nonoperating Liabilities
- 8.98 9.14
Total Noncurrent Liabilities
24 41 39
Long-Term Debt
18 37 35
Capital Lease Obligations
0.44 0.19 0.15
Noncurrent Deferred Revenue
1.06 0.92 0.90
Other Noncurrent Operating Liabilities
5.35 2.61 2.43
Other Noncurrent Nonoperating Liabilities
- 0.00 0.00
Total Equity & Noncontrolling Interests
10 -3.23 36
Total Preferred & Common Equity
10 -3.23 36
Total Common Equity
10 -3.23 36
Common Stock
158 159 202
Retained Earnings
-138 -152 -157
Treasury Stock
-1.02 -1.02 -1.02
Accumulated Other Comprehensive Income / (Loss)
-8.87 -8.58 -8.61

Annual Metrics And Ratios for FocalTherics

This table displays calculated financial ratios and metrics derived from FocalTherics' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
25,383,461.00 28,727,616.00 28,997,866.00 28,997,866.00 29,141,566.00 29,165,316.00 33,466,136.00 36,910,925.00 37,103,779.00 37,392,086.00 37,392,086.00
DEI Adjusted Shares Outstanding
25,383,461.00 28,727,616.00 28,997,866.00 28,997,866.00 29,141,566.00 29,165,316.00 33,466,136.00 36,910,925.00 37,103,779.00 37,392,086.00 37,392,086.00
DEI Earnings Per Adjusted Shares Outstanding
-0.07 0.14 -0.03 -0.01 0.06 -0.07 0.02 -0.09 -0.63 -0.55 -0.78
Growth Metrics
- - - - - - - - - - -
Revenue Growth
8.13% 6.90% 14.62% 4.44% 12.39% 0.98% -2.01% 18.21% 13.38% 3.82% 1.63%
EBITDA Growth
255.15% -32.77% -202.39% 158.23% 396.28% -73.79% 143.53% -125.76% -2,701.82% 16.94% -7.32%
EBIT Growth
149.19% -59.62% -777.28% 74.79% 394.92% -150.77% 163.58% -394.69% -858.29% 12.67% -23.09%
NOPAT Growth
125.24% -3.95% -578.08% 1,592.29% -93.30% -86.51% -721.73% -122.91% -381.26% -1.40% -11.11%
Net Income Growth
-192.37% 323.15% -120.25% 52.74% 538.66% -222.65% 138.06% -496.12% -646.60% 12.13% -42.08%
EPS Growth
-250.00% 285.71% -115.38% 50.00% 600.00% -220.00% 133.33% -581.50% -554.72% 12.77% -41.82%
Operating Cash Flow Growth
207.42% -3.50% -388.91% 105.45% 2,029.22% -43.37% 108.31% -164.30% -401.90% 9.45% -11.60%
Free Cash Flow Firm Growth
242.40% -122.94% -911.96% 453.73% -110.75% 133.75% -208.31% -589.15% -155.70% 12.63% -1.49%
Invested Capital Growth
-41.66% 26.54% 115.68% -26.13% 54.46% -5.95% -2.43% 36.55% 26.05% 7.99% 1.03%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
42.74% 46.08% 41.43% 43.17% 46.76% 44.11% 41.81% 43.90% 40.40% 41.42% 42.54%
EBITDA Margin
6.79% 4.27% -3.81% 2.13% 9.39% 2.44% 6.05% -1.32% -32.60% -26.08% -27.54%
Operating Margin
1.51% 1.10% -5.67% -3.36% 4.90% 0.65% -3.66% -7.72% -32.79% -32.03% -35.01%
EBIT Margin
3.68% 1.39% -8.21% -1.98% 5.20% -2.62% 1.70% -4.23% -35.77% -30.08% -36.44%
Profit (Net Income) Margin
-5.17% 10.79% -1.91% -0.86% 3.37% -4.09% 1.59% -5.32% -35.05% -29.66% -41.47%
Tax Burden Percent
183.79% 86.45% 232.54% -1,690.01% 69.01% 143.41% 78.38% 139.94% 103.14% 101.55% 101.52%
Interest Burden Percent
-76.41% 897.78% 9.98% -2.57% 93.75% 108.99% 119.39% 89.88% 95.01% 97.10% 112.11%
Effective Tax Rate
0.00% 13.55% 0.00% 1,790.02% 30.99% 0.00% 21.61% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
6.29% 7.24% -19.63% 246.65% 15.29% 1.75% -11.37% -21.70% -80.03% -69.97% -74.49%
ROIC Less NNEP Spread (ROIC-NNEP)
25.95% -16.12% -24.23% 381.96% 15.33% 14.41% -18.37% -21.80% -64.06% -53.49% 79.99%
Return on Net Nonoperating Assets (RNNOA)
-16.95% 12.28% 16.71% -247.97% -9.56% -8.38% 13.16% 16.99% 46.47% 30.93% -20.01%
Return on Equity (ROE)
-10.65% 19.52% -2.93% -1.32% 5.73% -6.63% 1.79% -4.71% -33.56% -39.04% -94.50%
Cash Return on Invested Capital (CROIC)
58.91% -16.19% -92.92% 276.71% -27.52% 7.88% -8.92% -52.61% -103.08% -77.66% -75.51%
Operating Return on Assets (OROA)
3.19% 1.15% -12.98% -1.59% 4.55% -2.10% 1.09% -2.55% -22.83% -21.90% -30.52%
Return on Assets (ROA)
-4.48% 8.89% -3.01% -0.69% 2.94% -3.28% 1.02% -3.21% -22.37% -21.59% -34.73%
Return on Common Equity (ROCE)
-10.65% 19.52% -5.67% -1.32% 5.73% -6.63% 1.79% -4.71% -33.56% -39.04% -94.50%
Return on Equity Simple (ROE_SIMPLE)
-11.55% 15.71% -2.71% -1.35% 5.53% -6.49% 1.40% -4.09% -37.20% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
0.37 0.36 -1.70 25 1.70 0.23 -1.43 -3.19 -15 -16 -17
NOPAT Margin
1.06% 0.95% -3.97% 56.72% 3.38% 0.45% -2.87% -5.41% -22.95% -22.42% -24.51%
Net Nonoperating Expense Percent (NNEP)
-19.66% 23.36% 4.59% -135.31% -0.04% -12.66% 6.99% 0.10% -15.97% -16.49% -154.48%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -3.77% -21.89% -28.77% -39.49%
Cost of Revenue to Revenue
57.26% 53.92% 58.57% 56.83% 53.24% 55.89% 58.19% 56.10% 59.60% 58.58% 57.46%
SG&A Expenses to Revenue
9.93% 9.26% 9.59% 9.17% 9.41% 10.41% 13.39% 12.98% 24.22% 21.97% 25.13%
R&D to Revenue
8.34% 10.86% 10.86% 10.43% 8.30% 10.79% 7.72% 8.93% 11.52% 12.05% 13.70%
Operating Expenses to Revenue
41.23% 44.99% 47.10% 46.53% 41.86% 43.47% 45.46% 51.63% 73.19% 73.45% 77.55%
Earnings before Interest and Taxes (EBIT)
1.29 0.52 -3.53 -0.89 2.62 -1.33 0.85 -2.49 -24 -21 -26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2.38 1.60 -1.64 0.95 4.73 1.24 3.02 -0.78 -22 -18 -19
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 3.24 2.73 1.88 4.18 4.70 3.08 4.66 3.10 1.93 6.34
Price to Tangible Book Value (P/TBV)
0.00 3.62 3.09 2.16 4.73 5.35 3.29 4.87 3.30 2.11 8.32
Price to Revenue (P/Rev)
0.00 2.22 1.92 1.20 2.55 2.96 3.50 6.05 2.92 1.18 1.74
Price to Earnings (P/E)
0.00 20.60 0.00 0.00 75.70 0.00 220.54 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 4.85% 0.00% 0.00% 1.32% 0.00% 0.45% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 11.46 5.40 4.41 8.22 10.32 10.50 17.52 7.20 2.71 5.44
Enterprise Value to Revenue (EV/Rev)
0.00 1.68 1.49 0.86 2.21 2.58 2.62 5.04 2.30 0.90 1.80
Enterprise Value to EBITDA (EV/EBITDA)
0.00 39.42 0.00 40.54 23.52 105.91 43.21 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 121.04 0.00 0.00 42.43 0.00 154.11 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 176.80 0.00 1.52 65.29 570.91 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 49.56 0.00 192.99 26.10 54.38 25.93 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 1.35 0.00 126.84 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.29 0.11 0.19 0.26 0.20 0.34 0.16 0.10 0.11 0.27 1.26
Long-Term Debt to Equity
0.06 0.03 0.05 0.09 0.06 0.06 0.11 0.05 0.04 0.06 0.84
Financial Leverage
-0.65 -0.76 -0.69 -0.65 -0.62 -0.58 -0.72 -0.78 -0.73 -0.58 -0.25
Leverage Ratio
2.38 2.20 1.88 1.91 1.95 2.02 1.75 1.47 1.50 1.81 2.72
Compound Leverage Factor
-1.82 19.72 0.19 -0.05 1.82 2.20 2.08 1.32 1.43 1.76 3.05
Debt to Total Capital
22.32% 10.15% 31.58% 20.32% 16.95% 25.25% 13.93% 9.32% 10.18% 21.44% 55.65%
Short-Term Debt to Total Capital
17.55% 7.59% 22.47% 13.32% 12.07% 20.42% 4.72% 4.36% 6.34% 16.62% 18.52%
Long-Term Debt to Total Capital
4.77% 2.56% 9.12% 6.99% 4.89% 4.84% 9.22% 4.95% 3.83% 4.83% 37.14%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
77.68% 89.85% 168.42% 79.68% 83.04% 74.74% 86.07% 90.68% 89.83% 78.56% 44.35%
Debt to EBITDA
1.89 1.82 -6.92 7.64 1.32 8.74 3.04 -10.12 -0.33 -0.64 -1.25
Net Debt to EBITDA
-4.77 -12.65 23.15 -15.73 -3.63 -15.59 -14.65 76.72 1.88 1.07 -0.20
Long-Term Debt to EBITDA
0.40 0.46 -2.00 2.63 0.38 1.67 2.01 -5.38 -0.12 -0.14 -0.84
Debt to NOPAT
12.14 8.15 -4.39 0.29 3.68 47.10 -6.41 -2.47 -0.47 -0.75 -1.41
Net Debt to NOPAT
-30.54 -56.73 22.23 -0.59 -10.07 -84.06 30.93 18.72 2.67 1.25 -0.23
Long-Term Debt to NOPAT
2.59 2.06 -1.27 0.10 1.06 9.02 -4.24 -1.31 -0.18 -0.17 -0.94
Altman Z-Score
0.00 2.43 3.96 1.37 3.21 2.75 4.06 7.48 2.63 -0.05 -0.92
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.03 2.70 4.91 2.40 2.41 2.11 3.75 4.17 2.84 1.85 1.54
Quick Ratio
1.62 2.13 4.01 1.95 1.91 1.72 3.30 3.60 2.27 1.33 1.16
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
3.47 -0.80 -8.07 29 -3.07 1.04 -1.12 -7.73 -20 -17 -18
Operating Cash Flow to CapEx
226.73% 102.98% -1,120.51% 71.43% 959.60% 372.32% 1,131.04% -493.31% -1,244.95% -1,033.24% -1,355.00%
Free Cash Flow to Firm to Interest Expense
1.53 0.00 0.00 0.00 -18.72 8.65 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.58 0.00 0.00 0.00 26.03 20.17 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.32 0.00 0.00 0.00 23.32 14.76 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.87 0.82 0.82 0.80 0.87 0.80 0.64 0.60 0.64 0.73 0.84
Accounts Receivable Turnover
3.49 3.52 3.71 3.30 3.83 3.84 3.82 4.42 3.92 3.55 3.47
Inventory Turnover
2.90 2.67 3.04 3.12 3.08 3.00 3.18 3.14 2.72 2.26 2.53
Fixed Asset Turnover
14.38 14.35 11.70 0.00 0.00 11.20 11.57 13.73 11.47 9.11 7.63
Accounts Payable Turnover
3.02 3.13 3.63 3.45 3.84 4.13 4.39 4.96 4.06 3.18 3.26
Days Sales Outstanding (DSO)
104.54 103.73 98.45 110.48 95.28 95.12 95.54 82.51 93.14 102.77 105.08
Days Inventory Outstanding (DIO)
125.80 136.71 120.03 117.09 118.57 121.51 114.74 116.37 134.32 161.30 144.30
Days Payable Outstanding (DPO)
120.84 116.52 100.49 105.90 95.17 88.28 83.08 73.66 89.83 114.92 112.06
Cash Conversion Cycle (CCC)
109.50 123.92 117.99 121.67 118.68 128.35 127.20 125.22 137.63 149.16 137.32
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
4.35 5.50 12 8.76 14 13 12 17 21 23 23
Invested Capital Turnover
5.94 7.61 4.95 4.35 4.52 3.88 3.97 4.01 3.49 3.12 3.04
Increase / (Decrease) in Invested Capital
-3.10 1.15 6.36 -3.10 4.77 -0.81 -0.31 4.54 4.42 1.71 0.24
Enterprise Value (EV)
0.00 63 64 39 111 131 130 297 154 63 127
Market Capitalization
0.00 83 82 54 128 151 175 357 195 82 123
Book Value per Share
$0.63 $1.01 $1.05 $0.99 $1.06 $1.10 $1.94 $2.29 $1.71 $1.15 $0.52
Tangible Book Value per Share
$0.52 $0.91 $0.93 $0.86 $0.94 $0.97 $1.82 $2.19 $1.60 $1.05 $0.40
Total Capital
20 29 36 36 37 43 66 85 70 54 44
Total Debt
4.51 2.91 5.67 7.28 6.27 11 9.17 7.87 7.13 12 24
Total Long-Term Debt
0.96 0.73 1.64 2.51 1.81 2.07 6.07 4.18 2.69 2.61 16
Net Debt
-11 -20 -18 -15 -17 -19 -44 -60 -41 -19 3.91
Capital Expenditures (CapEx)
0.58 1.24 0.66 0.28 0.44 0.65 0.44 0.66 1.30 1.42 1.21
Debt-free, Cash-free Net Working Capital (DFCFNWC)
5.92 5.86 8.16 9.47 8.63 7.77 5.65 9.76 13 11 7.68
Debt-free Net Working Capital (DFNWC)
22 29 32 32 32 38 59 77 61 42 28
Net Working Capital (NWC)
18 27 28 27 28 29 56 74 56 33 20
Net Nonoperating Expense (NNE)
2.18 -3.69 -0.89 26 0.01 2.31 -2.22 -0.05 8.08 5.03 12
Net Nonoperating Obligations (NNO)
-11 -20 -18 -20 -17 -19 -44 -60 -42 -19 3.91
Total Depreciation and Amortization (D&A)
1.09 1.08 1.89 1.84 2.11 2.57 2.17 1.72 2.12 2.78 6.27
Debt-free, Cash-free Net Working Capital to Revenue
16.90% 15.64% 39.21% 21.12% 17.13% 15.27% 11.33% 16.55% 18.92% 16.29% 10.89%
Debt-free Net Working Capital to Revenue
62.10% 77.39% 154.71% 70.79% 63.63% 74.55% 118.40% 131.12% 90.86% 60.95% 39.88%
Net Working Capital to Revenue
51.99% 71.58% 135.33% 60.14% 54.78% 57.34% 112.18% 124.86% 84.21% 48.00% 28.39%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.07) $0.14 ($0.02) ($0.01) $0.05 ($0.06) $0.02 ($0.09) ($0.57) ($0.53) ($0.78)
Adjusted Weighted Average Basic Shares Outstanding
25.02M 27.82M 28.96M 29.00M 29.02M 29.15M 32.13M 34.39M 37.00M 37.29M 37.44M
Adjusted Diluted Earnings per Share
($0.07) $0.13 ($0.02) ($0.01) $0.05 ($0.06) $0.02 ($0.09) ($0.57) ($0.53) ($0.78)
Adjusted Weighted Average Diluted Shares Outstanding
25.02M 29.37M 28.96M 29.00M 29.62M 29.15M 32.42M 34.39M 37.00M 37.29M 37.44M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
25.38M 28.73M 29.00M 29.00M 29.14M 29.17M 33.47M 36.91M 37.10M 37.39M 37.48M
Normalized Net Operating Profit after Tax (NOPAT)
0.37 0.36 -1.70 -1.05 1.70 0.23 -1.43 -3.19 -15 -16 -17
Normalized NOPAT Margin
1.06% 0.95% -3.97% -2.35% 3.38% 0.45% -2.87% -5.41% -22.95% -22.42% -24.51%
Pre Tax Income Margin
-2.81% 12.48% -0.82% 0.05% 4.88% -2.85% 2.03% -3.80% -33.98% -29.21% -40.85%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.57 0.00 0.00 0.00 16.01 -11.12 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.16 0.00 0.00 0.00 10.40 1.92 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.31 0.00 0.00 0.00 13.29 -16.54 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-0.09 0.00 0.00 0.00 7.69 -3.50 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for FocalTherics

This table displays calculated financial ratios and metrics derived from FocalTherics' official financial filings.

Metric Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
37,392,086.00 37,392,086.00 37,392,086.00 37,481,986.00 37,481,986.00 37,527,950.00
DEI Adjusted Shares Outstanding
37,392,086.00 37,392,086.00 37,392,086.00 37,481,986.00 37,481,986.00 37,527,950.00
DEI Earnings Per Adjusted Shares Outstanding
-0.20 -0.17 -0.16 -0.24 -0.39 -0.12
Growth Metrics
- - - - - -
Revenue Growth
0.00% 0.00% 0.00% 24.85% 38.85% 25.55%
EBITDA Growth
0.00% 0.00% 0.00% 29.20% 84.36% -44.54%
EBIT Growth
0.00% 0.00% 0.00% 1.24% -29.52% -11.03%
NOPAT Growth
0.00% 0.00% 0.00% -16.75% -21.29% -16.61%
Net Income Growth
0.00% 0.00% 0.00% -22.01% -126.15% 24.88%
EPS Growth
0.00% 0.00% 0.00% -20.00% -129.41% 37.50%
Operating Cash Flow Growth
0.00% 0.00% 0.00% 44.37% 21.55% -2.97%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth
0.00% -33.35% -17.68% 0.00% -25.88% -25.56%
EBITDA Q/Q Growth
0.00% 17.48% -5.02% 0.00% 81.77% -870.48%
EBIT Q/Q Growth
0.00% 14.41% -5.16% 0.00% -12.25% 9.85%
NOPAT Q/Q Growth
0.00% -4.98% -0.69% 0.00% -9.06% 3.19%
Net Income Q/Q Growth
0.00% 13.95% 7.27% 0.00% -59.50% 69.20%
EPS Q/Q Growth
0.00% 15.00% 5.88% 0.00% -62.50% 74.36%
Operating Cash Flow Q/Q Growth
0.00% 11.92% 16.94% 0.00% -24.19% -9.02%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 47.49% 0.34%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% -62.20% 1.79%
Profitability Metrics
- - - - - -
Gross Margin
42.01% 51.14% 46.59% 45.73% 55.58% 51.41%
EBITDA Margin
-45.99% -56.95% -72.65% -26.08% -6.42% -83.64%
Operating Margin
-44.22% -69.65% -85.19% -41.35% -60.84% -79.13%
EBIT Margin
-51.27% -65.84% -84.11% -40.56% -61.42% -74.38%
Profit (Net Income) Margin
-52.18% -67.37% -75.88% -50.99% -109.73% -45.40%
Tax Burden Percent
101.98% 101.04% 89.39% 101.62% 100.58% 84.64%
Interest Burden Percent
99.79% 101.26% 100.93% 123.73% 177.63% 72.12%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% -216.26% -883.68% -1,158.16%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% -296.98% -1,049.03% -1,165.10%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% -286.05% 3,487.34% 917.73%
Return on Equity (ROE)
0.00% 0.00% 0.00% -502.31% 2,603.67% -240.42%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% -41.69% -64.07% -53.59%
Return on Assets (ROA)
0.00% 0.00% 0.00% -52.42% -114.46% -32.71%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% -502.31% 2,603.67% -240.42%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-4.42 -4.64 -4.67 -5.16 -5.62 -5.44
NOPAT Margin
-30.95% -48.75% -59.64% -28.95% -42.59% -55.39%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 80.72% 165.36% 6.94%
Return On Investment Capital (ROIC_SIMPLE)
- - - -14.80% -15.25% -7.55%
Cost of Revenue to Revenue
57.99% 48.86% 53.41% 54.27% 44.42% 48.60%
SG&A Expenses to Revenue
25.60% 41.00% 48.97% 32.51% 41.80% 45.36%
R&D to Revenue
18.10% 24.09% 29.42% 14.58% 17.55% 25.01%
Operating Expenses to Revenue
86.23% 120.78% 131.80% 87.09% 116.42% 130.55%
Earnings before Interest and Taxes (EBIT)
-7.32 -6.26 -6.58 -7.22 -8.11 -7.31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-6.56 -5.42 -5.69 -4.65 -0.85 -8.22
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 13.80 0.00 4.67
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 24.87 0.00 5.03
Price to Revenue (P/Rev)
0.00 0.00 0.00 1.88 2.50 2.10
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 7.52 28.38 19.35
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 2.01 2.74 1.85
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.00 2.45 -12.43 1.01
Long-Term Debt to Equity
0.00 0.00 0.00 1.79 -11.59 0.98
Financial Leverage
0.00 0.00 0.00 0.96 -3.32 -0.79
Leverage Ratio
0.00 0.00 0.00 7.13 -23.12 3.08
Compound Leverage Factor
0.00 0.00 0.00 8.83 -41.06 2.22
Debt to Total Capital
0.00% 0.00% 0.00% 71.01% 108.75% 50.15%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 19.24% 7.34% 1.06%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 51.77% 101.40% 49.09%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 0.00% 0.00% 28.99% -8.75% 49.86%
Debt to EBITDA
0.00 0.00 0.00 -1.41 -3.10 -2.34
Net Debt to EBITDA
0.00 0.00 0.00 -0.56 -1.43 1.30
Long-Term Debt to EBITDA
0.00 0.00 0.00 -1.03 -2.89 -2.29
Debt to NOPAT
0.00 0.00 0.00 -1.37 -2.11 -1.83
Net Debt to NOPAT
0.00 0.00 0.00 -0.54 -0.98 1.02
Long-Term Debt to NOPAT
0.00 0.00 0.00 -1.00 -1.97 -1.79
Altman Z-Score
0.00 0.00 0.00 -0.41 -0.32 0.50
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
0.00 0.00 0.00 1.34 1.60 2.63
Quick Ratio
0.00 0.00 0.00 0.94 0.88 1.86
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 0.00 -25 -13 -13
Operating Cash Flow to CapEx
-11,613.04% -29,406.25% -1,091.62% -733.83% -1,902.58% -2,409.58%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.00 0.00 1.03 1.04 0.72
Accounts Receivable Turnover
0.00 0.00 0.00 3.77 7.73 7.84
Inventory Turnover
0.00 0.00 0.00 3.14 5.23 5.25
Fixed Asset Turnover
0.00 0.00 0.00 7.26 9.01 8.81
Accounts Payable Turnover
0.00 0.00 0.00 3.34 4.17 4.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 96.84 47.22 46.57
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 116.09 69.82 69.52
Days Payable Outstanding (DPO)
0.00 0.00 0.00 109.16 87.55 91.31
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 103.77 29.48 24.78
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 0.00 0.00 20 7.50 7.63
Invested Capital Turnover
0.00 0.00 0.00 7.47 20.75 20.91
Increase / (Decrease) in Invested Capital
0.00 0.00 0.00 20 7.50 7.63
Enterprise Value (EV)
0.00 0.00 0.00 149 213 148
Market Capitalization
73 62 86 139 194 168
Book Value per Share
$0.00 $0.00 $0.00 $0.27 ($0.09) $0.96
Tangible Book Value per Share
$0.00 $0.00 $0.00 $0.15 ($0.15) $0.89
Total Capital
0.00 0.00 0.00 35 37 72
Total Debt
0.00 0.00 0.00 25 40 36
Total Long-Term Debt
0.00 0.00 0.00 18 37 35
Net Debt
0.00 0.00 0.00 9.73 19 -20
Capital Expenditures (CapEx)
0.05 0.02 0.36 0.41 0.19 0.17
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 0.00 0.00 4.55 3.33 3.21
Debt-free Net Working Capital (DFNWC)
0.00 0.00 0.00 20 25 59
Net Working Capital (NWC)
0.00 0.00 0.00 13 22 59
Net Nonoperating Expense (NNE)
3.03 1.77 1.27 3.93 8.86 -0.98
Net Nonoperating Obligations (NNO)
0.00 0.00 0.00 9.73 11 -28
Total Depreciation and Amortization (D&A)
0.75 0.85 0.90 2.58 7.26 -0.91
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 6.14% 4.28% 4.02%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 26.41% 31.99% 74.57%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 17.36% 28.50% 73.61%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 ($0.24) ($0.39) ($0.10)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 37.48M 37.53M 42.63M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 ($0.24) ($0.39) ($0.10)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 37.48M 37.53M 42.63M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 37.48M 37.53M 47.22M
Normalized Net Operating Profit after Tax (NOPAT)
-4.42 -4.64 -4.67 -5.16 -5.62 -5.44
Normalized NOPAT Margin
-30.95% -48.75% -59.64% -28.95% -42.59% -55.39%
Pre Tax Income Margin
-51.17% -66.67% -84.89% -50.18% -109.10% -53.64%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

FocalTherics’ available financial data shows strong revenue growth and improving gross margins, but the company remains deeply unprofitable and increasingly dependent on debt financing. The data provided covers the first two quarters of 2025 and 2026 rather than a full four-year period. It also identifies the reporting entity as EDAP TMS SA, so investors should verify the company and ticker information before relying on these figures.

  • Revenue growth accelerated. Second-quarter 2026 revenue rose to $13.2 million from $9.5 million a year earlier, an increase of approximately 39%. First-quarter revenue also increased 25% year over year to $17.8 million.
  • Gross margins improved. Second-quarter gross margin expanded to approximately 55.6%, compared with 51.1% in the prior-year quarter. First-quarter gross margin also improved to about 45.7% from 42.0%.
  • Operating cash burn improved year over year in the second quarter. Cash used in operating activities declined to $3.7 million from $4.7 million in Q2 2025, despite the company reporting a larger net loss.
  • Liquidity increased during the second quarter. Cash and equivalents rose to $21.5 million at June 30, 2026, from $15.0 million at March 31, 2026. Total current assets also increased to $59.0 million from $50.4 million.
  • Near-term liquidity coverage improved. The current ratio increased to approximately 1.6 in Q2 2026 from 1.3 in Q1 2026, although this improvement was partly driven by new debt financing rather than internally generated cash.
  • Noncash expenses significantly affected reported earnings. Second-quarter depreciation, amortization and other noncash adjustments totaled approximately $8.2 million. The large amortization charge helped reduce the gap between the reported net loss and operating cash flow, but it does not eliminate the company’s underlying cash needs.
  • Accounts receivable and inventory declined. Accounts receivable fell to $10.1 million from $19.7 million at the end of Q1, while inventory declined to $8.3 million from $13.3 million. This may reflect stronger collections and inventory management, although the reasons for the changes are not provided.
  • Losses remain substantial. Second-quarter 2026 net loss widened to $14.5 million from $6.4 million in Q2 2025. The quarterly loss increased to $0.39 per share from $0.17 per share.
  • Operating expenses continue to exceed gross profit. Second-quarter operating expenses were $15.4 million, more than twice the $7.3 million gross profit. The resulting operating loss expanded to $8.0 million from $6.6 million a year earlier.
  • Balance-sheet leverage and solvency are major risks. Total liabilities reached $77.8 million compared with $74.5 million of assets, producing negative shareholders’ equity of $3.2 million. Long-term debt increased to $37.2 million from $17.6 million in Q1, while the company issued approximately $12.4 million of debt during the second quarter.

Overall, the operating picture is mixed. Revenue and gross margins are moving in the right direction, and quarterly operating cash burn improved compared with the prior-year period. However, those gains have not yet translated into profitability, and the company’s negative equity, rising debt burden and continued cash consumption leave it exposed to refinancing needs and potential shareholder dilution.

11/16/26 09:34 PM ETAI Generated. May Contain Errors.

FocalTherics Financials - Frequently Asked Questions

According to the most recent income statement we have on file, FocalTherics' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

FocalTherics' net income appears to be on a downward trend, with a most recent value of -$29.25 million in 2025, falling from -$1.81 million in 2015. The previous period was -$20.58 million in 2024. See FocalTherics' forecast for analyst expectations on what's next for the company.

FocalTherics' total operating income in 2025 was -$24.69 million, based on the following breakdown:
  • Total Gross Profit: $30.00 million
  • Total Operating Expenses: $54.70 million

Over the last 10 years, FocalTherics' total revenue changed from $35.04 million in 2015 to $70.53 million in 2025, a change of 101.3%.

In the past 2 quarters, FocalTherics' cash and equivalents has ranged from $15.01 million in Q1 2026 to $56.27 million in Q3 2026, and is currently $56.27 million as of their latest financial filing in Q3 2026.

FocalTherics had total debt of $24.36 million at the end of 2025, a 110.1% increase from 2024, and a 440.7% increase since 2015.

Over the last 10 years, FocalTherics' book value per share changed from 0.63 in 2015 to 0.52 in 2025, a change of -17.1%.



Financial statements for NASDAQ:FOCL last updated on 11/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners